$CVM #nasdaq CEL-SCI Corporation is a biotechnology firm

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

3D Marketing & Services Enhances PR Operations for Growth 3D Marketing & Services LLC is making substantial strides in the realm of public relations (PR) and marketing strategies. With a reputation for excellence in PR distribution and digital marketing, the agency is expanding its operations to meet the growing industry demand. This strategic move includes broadening...

Hydro Ottawa Marks 10 Years of Safety and Compliance Partnership In a significant milestone, Hydro Ottawa proudly celebrates its ten-year partnership with ISN. This collaboration has been pivotal in establishing a robust framework for contractor safety and compliance. Hydro Ottawa, recognized as a leading utility provider, has embraced ISNetworld since implementation,...

Venus Concept Reaches Important Regulatory Milestone Venus Concept Inc. (NASDAQ: VERO), a well-known player in medical aesthetic technology, is thrilled to share that it has received approval from Australia's Therapeutic Goods Administration (TGA) for its groundbreaking Venus Bliss MAX system. This device is poised to transform body shaping treatments, providing solutions...

Upcoming Special Meeting for Shareholders of ReShape Lifesciences Inc The Board of Directors of ReShape Lifesciences Inc has announced a special meeting to engage with shareholders regarding pivotal proposals linked to a potential merger. Importance of the Special Meeting Scheduled for 11:30 AM ET on July 24, this meeting aims to discuss the merger with Vyome Therapeutics...

ManpowerGroup's Dividend Announcement The Board of Directors of ManpowerGroup (NYSE: MAN) has officially declared a semi-annual dividend, amounting to $1.54 per share. This positive news is part of the company's ongoing commitment to deliver value to its shareholders. Details of the Dividend Shareholders of record will receive this dividend payment on December 16,...